BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32949573)

  • 1. Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model.
    Pion E; Asam C; Feder AL; Felthaus O; Heidekrueger PI; Prantl L; Haerteis S; Aung T
    Microvasc Res; 2021 Jan; 133():104072. PubMed ID: 32949573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Laser Speckle Contrast Imaging (LSCI) for the Angiogenesis Measurement of Tumors in the Chorioallantoic Membrane (CAM) Model.
    Pion E; Haerteis S; Aung T
    Methods Mol Biol; 2023; 2572():141-153. PubMed ID: 36161414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning-Based Image Analysis for the Quantification of Tumor-Induced Angiogenesis in the 3D In Vivo Tumor Model-Establishment and Addition to Laser Speckle Contrast Imaging (LSCI).
    Kuri PM; Pion E; Mahl L; Kainz P; Schwarz S; Brochhausen C; Aung T; Haerteis S
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a chick embryo chorioallantoic membrane (CAM) based platform for evaluation of vasoactive medications.
    Chen L; Wang S; Feng Y; Yu J; Coudyzer W; Van Ongeval C; Geng L; Li Y; Ni Y
    Microvasc Res; 2022 Jul; 142():104372. PubMed ID: 35483521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Critically Perfused Tissues by Laser Speckle Contrast Analysis (LASCA) Perfusion Imaging].
    Limbourg A; Radtke C; Ipaktchi R; Vogt PM
    Handchir Mikrochir Plast Chir; 2016 Dec; 48(6):354-362. PubMed ID: 28033625
    [No Abstract]   [Full Text] [Related]  

  • 6. Methods for Analyzing Tumor Angiogenesis in the Chick Chorioallantoic Membrane Model.
    Ames JJ; Henderson T; Liaw L; Brooks PC
    Methods Mol Biol; 2016; 1406():255-69. PubMed ID: 26820962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D monitoring of tumor volume in an in vivo model.
    Troebs J; Asam C; Pion E; Prantl L; Aung T; Haerteis S
    Clin Hemorheol Microcirc; 2020; 76(2):123-131. PubMed ID: 32925020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chick ex ovo culture and ex ovo CAM assay: how it really works.
    Dohle DS; Pasa SD; Gustmann S; Laub M; Wissler JH; Jennissen HP; Dünker N
    J Vis Exp; 2009 Nov; (33):. PubMed ID: 19949373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.
    Kennedy DC; Coen B; Wheatley AM; McCullagh KJA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients.
    Cutolo M; Vanhaecke A; Ruaro B; Deschepper E; Ickinger C; Melsens K; Piette Y; Trombetta AC; De Keyser F; Smith V;
    Autoimmun Rev; 2018 Aug; 17(8):775-780. PubMed ID: 29885540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Shoji C; Kikuchi K; Yoshida H; Miyachi M; Yagyu S; Tsuchiya K; Nakaya T; Hosoi H; Iehara T
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36866753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chick chorioallantoic membrane as an in vivo xenograft model for Burkitt lymphoma.
    Klingenberg M; Becker J; Eberth S; Kube D; Wilting J
    BMC Cancer; 2014 May; 14():339. PubMed ID: 24884418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
    As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
    Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A; Aigner A; Bakowsky U
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution MRI analysis of breast cancer xenograft on the chick chorioallantoic membrane.
    Zuo Z; Syrovets T; Genze F; Abaei A; Ma G; Simmet T; Rasche V
    NMR Biomed; 2015 Apr; 28(4):440-7. PubMed ID: 25711154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
    Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
    Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random process estimator for laser speckle imaging of cerebral blood flow.
    Miao P; Li N; Thakor NV; Tong S
    Opt Express; 2010 Jan; 18(1):218-36. PubMed ID: 20173842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
    Tufan AC; Satiroglu-Tufan NL
    Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Improved
    Mangir N; Raza A; Haycock JW; Chapple C; Macneil S
    In Vivo; 2018; 32(3):461-472. PubMed ID: 29695547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.